To evaluate the characteristics of blood glucose fluctuation and safety and efficacy of sitagliptin in end-stage type 2 diabetic nephropathy on peritoneal dialysis
Latest Information Update: 07 Jul 2016
At a glance
- Drugs Sitagliptin (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 03 Jul 2016 Status changed from recruiting to completed.
- 17 Feb 2014 New trial record